Literature DB >> 19933705

Relationship between N-acetyltransferase 2 single-nucleotide polymorphisms and phenotype.

David W Hein, Lori M Millner, Carmine S Leggett, Mark A Doll.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19933705      PMCID： PMC2812573          DOI： 10.1093/carcin/bgp290

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN： 0143-3334            Impact factor:   4.944


× No keyword cloud information.
  12 in total

1.  Update on consensus arylamine N-acetyltransferase gene nomenclature.

Authors:  D W Hein; D M Grant; E Sim
Journal:  Pharmacogenetics       Date:  2000-06

Review 2.  Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.

Authors:  D W Hein; M A Doll; A J Fretland; M A Leff; S J Webb; G H Xiao; U S Devanaboyina; N A Nangju; Y Feng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-01       Impact factor: 4.254

3.  Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2.

Authors:  Yu Zang; Mark A Doll; Shuang Zhao; J Christopher States; David W Hein
Journal:  Carcinogenesis       Date:  2007-04-13       Impact factor: 4.944

4.  Molecular mechanism of slow acetylation of drugs and carcinogens in humans.

Authors:  M Blum; A Demierre; D M Grant; M Heim; U A Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

5.  The T341C (Ile114Thr) polymorphism of N-acetyltransferase 2 yields slow acetylator phenotype by enhanced protein degradation.

Authors:  Yu Zang; Shuang Zhao; Mark A Doll; J Christopher States; David W Hein
Journal:  Pharmacogenetics       Date:  2004-11

6.  NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women.

Authors:  Olga L van der Hel; Petra H M Peeters; David W Hein; Mark A Doll; Diederick E Grobbee; Daan Kromhout; H Bas Bueno de Mesquita
Journal:  Pharmacogenetics       Date:  2003-07

7.  Impact of misclassification in genotype-exposure interaction studies: example of N-acetyltransferase 2 (NAT2), smoking, and bladder cancer.

Authors:  Anne C Deitz; Nathanial Rothman; Timothy R Rebbeck; Richard B Hayes; Wong-Ho Chow; Wei Zheng; David W Hein; Montserrat García-Closas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-09       Impact factor: 4.254

Review 8.  N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine.

Authors:  David W Hein
Journal:  Expert Opin Drug Metab Toxicol       Date:  2009-04       Impact factor: 4.481

Review 9.  N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk.

Authors:  D W Hein
Journal:  Oncogene       Date:  2006-03-13       Impact factor: 9.867

10.  Aromatic DNA adducts and polymorphisms in metabolic genes in healthy adults: findings from the EPIC-Spain cohort.

Authors:  Antonio Agudo; Marco Peluso; Núria Sala; Gabriel Capellá; Armelle Munnia; Sara Piro; Fátima Marín; Raquel Ibáñez; Pilar Amiano; M José Tormo; Eva Ardanaz; Aurelio Barricarte; M Dolores Chirlaque; Miren Dorronsoro; Nerea Larrañaga; Carmen Martínez; Carmen Navarro; J Ramón Quirós; M José Sánchez; Carlos A González
Journal:  Carcinogenesis       Date:  2009-03-23       Impact factor: 4.944
View more
  4 in total

Review 1.  Causes of genome instability: the effect of low dose chemical exposures in modern society.

Authors:  Sabine A S Langie; Gudrun Koppen; Daniel Desaulniers; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Amaya Azqueta; William H Bisson; Dustin G Brown; Gunnar Brunborg; Amelia K Charles; Tao Chen; Annamaria Colacci; Firouz Darroudi; Stefano Forte; Laetitia Gonzalez; Roslida A Hamid; Lisbeth E Knudsen; Luc Leyns; Adela Lopez de Cerain Salsamendi; Lorenzo Memeo; Chiara Mondello; Carmel Mothersill; Ann-Karin Olsen; Sofia Pavanello; Jayadev Raju; Emilio Rojas; Rabindra Roy; Elizabeth P Ryan; Patricia Ostrosky-Wegman; Hosni K Salem; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Frederik J Van Schooten; Mahara Valverde; Jordan Woodrick; Luoping Zhang; Nik van Larebeke; Micheline Kirsch-Volders; Andrew R Collins
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

2.  N-acetyltransferase 2 genetic polymorphism modifies genotoxic and oxidative damage from new psychoactive substances.

Authors:  Raúl A Salazar-González; Mark A Doll; David W Hein
Journal:  Arch Toxicol       Date:  2022-09-23       Impact factor: 6.168

3.  No association between variant N-acetyltransferase genes, cigarette smoking and Prostate Cancer susceptibility among men of African descent.

Authors:  La Creis Renee Kidd; Tiva T Vancleave; Mark A Doll; Daya S Srivastava; Brandon Thacker; Oyeyemi Komolafe; Vasyl Pihur; Guy N Brock; David W Hein
Journal:  Biomark Cancer       Date:  2011-02-03

4.  Differential association for N-acetyltransferase 2 genotype and phenotype with bladder cancer risk in Chinese population.

Authors:  Lei Quan; Koushik Chattopadhyay; Heather H Nelson; Kenneth K Chan; Yong-Bing Xiang; Wei Zhang; Renwei Wang; Yu-Tang Gao; Jian-Min Yuan
Journal:  Oncotarget       Date:  2016-06-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.